Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS

Neurology

Volumn 78, Issue 18, 2012, Pages 1390-1393

  Gheuens, S ^a   Smith, D R ^b   Wang, X ^a   Alsop, D C ^a   Lenkinski, R E ^a   Koralnik, I J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Thames Neurologic Institute Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; ETIRACETAM; INOSITOL; MEFLOQUINE; MEPREDNISONE; MIRTAZAPINE; NATALIZUMAB; PREDNISONE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; APHASIA; ARTICLE; ASPIRATION PNEUMONIA; ATAXIC APHASIA; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CEREBELLUM; CEREBELLUM ATROPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EVOKED VISUAL RESPONSE; FRONTAL LOBE; HUMAN; IMAGE ANALYSIS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; JC VIRUS; MALE; MONOTHERAPY; MULTIPLE SCLEROSIS; NEUROIMAGING; PARIETAL LOBE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL SIGN; PYRAMIDAL TRACT; SEIZURE; WHITE MATTER;

EID: 84860783795     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318253d61e     Document Type: Article

References (8)

1. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011;76:1697-1704.
2. Johnson T, Nath A. Neurological complications of immune reconstitution in HIV-infected populations. Ann NY Acad Sci 2010;1184:106-120.
3. O'Connor PW, Goodman A, Kappos L, et al. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 2011;76: 1858-1865.
4. Miravalle A, Jensen R, Kinkel RP. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol 2011;68:186-191.
5. Bonham S, Meya DB, Bohjanen PR, Boulware DR. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med 2008;2:349-361.
6. Gheuens S, Bord E, Kesari S, et al. Role of CD4 and CD8 T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 2011;85:7256-7263.
7. Katz-Brull R, Lenkinski RE, Du Pasquier RA, Koralnik IJ. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004;63:897-900. (Pubitemid 39297655)
8. Cuvinciuc V, Martin-Blondel G, Marchou B, Bonneville F. Proton MR spectroscopy of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome. AJNR Am J Neuroradiol 2010;31:E69- E70; author reply E71.